Pluristyx Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $9.8M

  • Investors
  • 4

Pluristyx General Information

Description

Developer of induced pluripotent stem cell technology intended to accelerate the development and commercialization of cellular therapies. The company offers induced pluripotent stem cells, gene editing, cellular reprogramming, cryopreservation services, differentiated cells, and cell banking, enabling biotechnology companies and researchers to develop and commercialize cell therapy products.

Contact Information

Website
www.pluristyx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 201 Elliott Avenue West
  • Seattle, WA 98119
  • United States
+1 (888)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 201 Elliott Avenue West
  • Seattle, WA 98119
  • United States
+1 (888)

Pluristyx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pluristyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 13-Jul-2026 $9.8M Completed Generating Revenue
2. Later Stage VC 28-Jul-2025 Completed Generating Revenue
1. Later Stage VC 01-Sep-2023 Completed Generating Revenue
To view Pluristyx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Pluristyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of induced pluripotent stem cell technology intended to accelerate the development and commercialization of ce
Biotechnology
Seattle, WA
16 As of 2026

New Brighton, MN
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pluristyx Competitors (2)

One of Pluristyx’s 2 competitors is Recombinetics, a Venture Capital-Backed company based in New Brighton, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recombinetics Venture Capital-Backed New Brighton, MN
Kytopen Venture Capital-Backed Cambridge, MA
You’re viewing 2 of 2 competitors. Get the full list »

Pluristyx Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Pluristyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024247977-A1 Conditionally immortalized stem cells and uses thereof Pending 31-Mar-2023
EP-4689077-A2 Conditionally immortalized stem cells and uses thereof Pending 31-Mar-2023
WO-2024206943-A2 Conditionally immortalized stem cells and uses thereof Inactive 31-Mar-2023
WO-2024206943-A3 Conditionally immortalized stem cells and uses thereof Inactive 31-Mar-2023
EP-4482945-A2 Methods of making induced pluripotent stem cells Pending 22-Feb-2022 C12N5/0696
To view Pluristyx’s complete patent history, request access »

Pluristyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pluristyx Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Syndicate Partners Corporation Minority
Biolife Solutions Corporation Minority
BroadOak Capital Partners Growth/Expansion Minority
Creative Destruction Lab Accelerator/Incubator Minority
To view Pluristyx’s complete investors history, request access »

Pluristyx Acquisitions (1)

Pluristyx’s most recent deal was a Merger/Acquisition with Pancella. The deal was made on 06-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pancella 06-Oct-2022 Merger/Acquisition Biotechnology
To view Pluristyx’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Pluristyx FAQs

  • When was Pluristyx founded?

    Pluristyx was founded in 2018.

  • Where is Pluristyx headquartered?

    Pluristyx is headquartered in Seattle, WA.

  • What is the size of Pluristyx?

    Pluristyx has 16 total employees.

  • What industry is Pluristyx in?

    Pluristyx’s primary industry is Biotechnology.

  • Is Pluristyx a private or public company?

    Pluristyx is a Private company.

  • What is Pluristyx’s current revenue?

    The current revenue for Pluristyx is .

  • How much funding has Pluristyx raised over time?

    Pluristyx has raised $9.8M.

  • Who are Pluristyx’s investors?

    Syndicate Partners, Biolife Solutions, BroadOak Capital Partners, and Creative Destruction Lab have invested in Pluristyx.

  • Who are Pluristyx’s competitors?

    Recombinetics and Kytopen are competitors of Pluristyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process